Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases

Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases

US Patent 6429207 · Granted Aug 6, 2002

Estimated economic value: $10,559,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-variable MUC1* antibodies and uses thereof2025
Agents for differentiating stem cells and treating cancer2025
Methods for deriving dopaminergic neurons from pluripotent stem cells2024
Method of screening for agents for differentiating stem cells2024
Endoparasitic depsipeptides2023
Endoparasitic depsipeptides2023
(Trifluoromethyl)pyrimidine-2-amine compounds2023
(trifluoromethyl)pyrimidine-2-amine compounds2022
Endoparasitic depsipeptides2022
Carboline antiparasitics2020
Ghrelin 0-acyl transferase inhibitors2019
Phenicol antibacterials2016